Expression of the Multiple Sclerosis-Associated MHC Class II Allele HLA-DRB1*1501 Is Regulated by Vitamin D

被引:348
|
作者
Ramagopalan, Sreeram V. [1 ,2 ]
Maugeri, Narelle J. [1 ]
Handunnetthi, Lahiru [1 ,2 ]
Lincoln, Matthew R. [1 ,2 ]
Orton, Sarah-Michelle [1 ,2 ]
Dyment, David A. [1 ,2 ]
DeLuca, Gabriele C. [1 ,2 ]
Herrera, Blanca M. [1 ,2 ]
Chao, Michael J. [1 ,2 ]
Sadovnick, A. Dessa [3 ,4 ]
Ebers, George C. [1 ,2 ]
Knight, Julian C. [1 ]
机构
[1] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England
[2] Univ Oxford, John Radcliffe Hosp, Dept Clin Neurol, Oxford OX3 9DU, England
[3] Univ British Columbia, Dept Med Genet, Div Neurol, UBC Hosp, Vancouver, BC, Canada
[4] Univ British Columbia, Fac Med, Div Neurol, UBC Hosp, Vancouver, BC, Canada
基金
英国惠康基金; 英国医学研究理事会;
关键词
LINKAGE DISEQUILIBRIUM; GENE-EXPRESSION; HLA-DR; RISK; SUSCEPTIBILITY; PREVALENCE; PROMOTER; CELLS;
D O I
10.1371/journal.pgen.1000369
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Multiple sclerosis (MS) is a complex trait in which allelic variation in the MHC class II region exerts the single strongest effect on genetic risk. Epidemiological data in MS provide strong evidence that environmental factors act at a population level to influence the unusual geographical distribution of this disease. Growing evidence implicates sunlight or vitamin D as a key environmental factor in aetiology. We hypothesised that this environmental candidate might interact with inherited factors and sought responsive regulatory elements in the MHC class II region. Sequence analysis localised a single MHC vitamin D response element (VDRE) to the promoter region of HLA-DRB1. Sequencing of this promoter in greater than 1,000 chromosomes from HLA-DRB1 homozygotes showed absolute conservation of this putative VDRE on HLA-DRB1*15 haplotypes. In contrast, there was striking variation among non-MS-associated haplotypes. Electrophoretic mobility shift assays showed specific recruitment of vitamin D receptor to the VDRE in the HLA-DRB1*15 promoter, confirmed by chromatin immunoprecipitation experiments using lymphoblastoid cells homozygous for HLA-DRB1*15. Transient transfection using a luciferase reporter assay showed a functional role for this VDRE. B cells transiently transfected with the HLA-DRB1*15 gene promoter showed increased expression on stimulation with 1,25-dihydroxyvitamin D3 (P=0.002) that was lost both on deletion of the VDRE or with the homologous "VDRE" sequence found in non-MS-associated HLA-DRB1 haplotypes. Flow cytometric analysis showed a specific increase in the cell surface expression of HLA-DRB1 upon addition of vitamin D only in HLA-DRB1*15 bearing lymphoblastoid cells. This study further implicates vitamin D as a strong environmental candidate in MS by demonstrating direct functional interaction with the major locus determining genetic susceptibility. These findings support a connection between the main epidemiological and genetic features of this disease with major practical implications for studies of disease mechanism and prevention.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Investigation of promoter HLA-DRB1 polymorphism in relation to a putative VDRE motif: HLA-DRB1 allele associations and influence on risk of multiple sclerosis
    Castley, A.
    Tschochner, M.
    James, I.
    Kermode, A.
    Carroll, W.
    Sayer, D.
    Christiansen, F.
    Witt, C.
    Nolan, D.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S334 - S334
  • [42] HLA-DRB1*1501 and response to copolymer-1 therapy in relapsing-remitting multiple sclerosis
    Fusco, C
    Andreone, V
    Cappola, G
    Luongo, V
    Guerini, F
    Pace, E
    Florio, C
    Pirozzi, G
    Lanzillo, R
    Ferrante, P
    Vivo, P
    Mini, M
    Macrì, M
    Orefice, G
    Lombardi, ML
    [J]. NEUROLOGY, 2001, 57 (11) : 1976 - 1979
  • [43] HLA-DRB1 and disease outcome in multiple sclerosis
    Weatherby, SJM
    Thomson, W
    Pepper, L
    Donn, R
    Worthington, J
    Mann, CLA
    Davies, MB
    Fryer, MB
    Fryer, AA
    Boggild, MD
    Young, CA
    Jones, PW
    Strange, RC
    Ollier, WER
    Hawkins, CP
    [J]. JOURNAL OF NEUROLOGY, 2001, 248 (04) : 304 - 310
  • [44] HLA-DRB1 and disease outcome in multiple sclerosis
    S. J. M. Weatherby
    W. Thomson
    L. Pepper
    R. Donn
    J. Worthington
    C. L. A. Mann
    M. B. Davies
    A. A. Fryer
    M. D. Boggild
    C. A. Young
    P. W. Jones
    R. C. Strange
    W. E. R. Ollier
    C. P. Hawkins
    [J]. Journal of Neurology, 2001, 248 : 304 - 310
  • [45] HLA-DRB1 and prognosis of multiple sclerosis in France
    Yaouanq, J
    Drapier, S
    Leray, E
    Le Page, E
    Chaperon, J
    Edan, G
    [J]. MULTIPLE SCLEROSIS, 2005, 11 : S118 - S118
  • [46] HLA-DRB1 and month of birth in multiple sclerosis
    Ramagopalan, S. V.
    Link, J.
    Byrnes, J. K.
    Dyment, D. A.
    Giovannoni, G.
    Hintzen, R. Q.
    Sundqvist, E.
    Kockum, I.
    Smestad, C.
    Lic, B. A.
    Harbo, H. F.
    Padyukov, L.
    Alfredsson, L.
    Olsson, T.
    Sadovnick, A. D.
    Hillert, J.
    Ebers, G. C.
    [J]. NEUROLOGY, 2009, 73 (24) : 2107 - 2111
  • [47] Response to immunosuppressive therapy and an HLA-DRB1 allele in patients with aplastic anaemia: HLA-DRB1*1501 does not predict response to antithymocyte globulin
    Nakao, S
    Takami, A
    Sugimori, N
    Ueda, M
    Shiobara, S
    Matsuda, T
    Mizoguchi, H
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 92 (01) : 155 - 158
  • [48] HLA-DRB1 and multiple sclerosis in a spanish population
    Romero-Pinel, L.
    Pujal, J. M.
    Gubieras, L.
    Matas, E.
    Bau, L.
    Martinez-Yelamos, S.
    Arbizu, T.
    [J]. JOURNAL OF NEUROLOGY, 2009, 256 : S35 - S36
  • [49] Combined effect of HLA-DRB1* 1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing/remitting multiple sclerosis
    delaConcha, EG
    Arroyo, R
    Crusius, JBA
    Campillo, JA
    Martin, C
    deSeijas, E
    Pena, AS
    Claveria, LE
    FernandezArquero, M
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 1997, 80 (1-2) : 172 - 178
  • [50] Human MHC-class II drives anti-FVIII immune responses in humanized HLA-DRB1*1501 hemophilic mice
    Reipert, B.
    Steinitz, K.
    Sasgary, M.
    Schuster, M.
    Ahmad, R.
    Schwarz, H.
    [J]. HAEMOPHILIA, 2008, 14 : 43 - 43